Tag: KDC-MN-124

  • P21 (Cerebrolysin-derived peptide)

    CNTF-derived neurogenic peptide

    A short peptide derived from a cerebrolysin fraction with documented hippocampal neurogenesis activity in animal models.

    Abstract

    P21 is a peptide of the sequence Ala-Asp-Asn-Phe-Val-Phe-Lys derived from the active fraction of cerebrolysin (or related neurotrophic preparations) and identified by Khalid Iqbal’s group at the New York State Institute for Basic Research. The compound stimulates neurogenesis in the dentate gyrus through a CNTF-receptor-related mechanism, producing dose-dependent improvements in spatial learning and memory in rodent models of cognitive aging and Alzheimer disease pathology. The compound has not been advanced to human clinical trials. Pharmacokinetics are poorly characterized in humans. The compound is sold as a research peptide; investigational doses parallel cerebrolysin range scaled to peptide content.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.